BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18829446)

  • 1. Explaining the race difference in prostate cancer stage at diagnosis.
    Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.
    Mettlin CJ; Murphy GP; Cunningham MP; Menck HR
    Cancer; 1997 Oct; 80(7):1261-6. PubMed ID: 9317177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
    Ryan CJ; Elkin EP; Small EJ; Duchane J; Carroll P
    Urol Oncol; 2006; 24(5):396-402. PubMed ID: 16962488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer incidence and survival in relation to education (United States).
    Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
    Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
    Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of prostate cancer stage in northern New England: USA Franco-American contextual effects.
    Parsons MA; Askland KD
    Soc Sci Med; 2007 Nov; 65(10):2018-30. PubMed ID: 17689162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
    Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer survival disparities by race/ethnicity and socioeconomic status in New Jersey.
    Niu X; Pawlish KS; Roche LM
    J Health Care Poor Underserved; 2010 Feb; 21(1):144-60. PubMed ID: 20173261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.
    Feuer EJ; Mariotto A; Merrill R
    Cancer; 2002 Aug; 95(4):870-80. PubMed ID: 12209732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic variation in health resource use and cost for prostate cancer.
    Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
    BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusters of census tracts with high proportions of men with distant-stage prostate cancer incidence in New Jersey, 1995 to 1999.
    Abe T; Martin IB; Roche LM
    Am J Prev Med; 2006 Feb; 30(2 Suppl):S60-6. PubMed ID: 16458791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
    Chan JM; Latini DM; Cowan J; Duchane J; Carroll PR
    Cancer Causes Control; 2005 Sep; 16(7):789-97. PubMed ID: 16132789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
    Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
    Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.
    Consedine NS; Morgenstern AH; Kudadjie-Gyamfi E; Magai C; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):228-37. PubMed ID: 16492909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer in Mexican-Americans: identification of risk factors.
    Strom SS; Yamamura Y; Flores-Sandoval FN; Pettaway CA; Lopez DS
    Prostate; 2008 Apr; 68(5):563-70. PubMed ID: 18247399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the colorectum in Maine, 1995-1998: determinants of stage at diagnosis in a rural state.
    Parsons MA; Askland KD
    J Rural Health; 2007; 23(1):25-32. PubMed ID: 17300475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of socioeconomic status and treatment disparities in colorectal cancer survival.
    Le H; Ziogas A; Lipkin SM; Zell JA
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1950-62. PubMed ID: 18708384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study.
    Byers TE; Wolf HJ; Bauer KR; Bolick-Aldrich S; Chen VW; Finch JL; Fulton JP; Schymura MJ; Shen T; Van Heest S; Yin X;
    Cancer; 2008 Aug; 113(3):582-91. PubMed ID: 18613122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.